Proposed INN - List 103
pINN
brentuximab vedotin
drozitumab
dulaglutide
elpamotide
ensituximab
foralumab
ganitumab
insulin tregopil
itolizumab
lorvotuzumab mertansine
nonacog beta pegol
olaratumab
olokizumab
oxelumab
peginesatide
pegsiticase
roledumab
samalizumab
somatropin pegol
tiprelestat
trastuzumab emtansine
▲
